Thomson Reuters Congress Reports

Meeting Summaries for the 16th International IRA Conference

As the official media partner to the Inflammation Research Association at the 16th International Conference on Inflammation, Thomson Reuters will be providing delegates with a collection of reviews featuring the latest intelligence on investigational drugs and research released at the Conference. The reviews will be written by an "on-site Conference reporter" from Thomson Reuter's Scientific division and will be accessible daily during the Conference through the official Conference WEB site.

Features of this Service

Available one week in advance of the Conference: Early birds can peruse the event preview to identify those sessions that are a 'must-see' for those working in the field of inflammation research.

Daily updates: Delegates can keep abreast of the hottest news as it unfolds by accessing daily reviews of the latest disclosures on drug discovery and research with three overnight reports available on the WEB site as the meeting progresses.

How to Access the Meeting Summaries

To access the meeting summaries, click here and enter your username password sent to all delegates by e-mail prior to the meeting.

If you do not have or have lost your password or you are experiencing difficulties in logging in, please contact Richard Griffiths (richard.j.griffiths@pfizer.com) for further assistance. While at the meeting, please contact the IRA registration desk in the case of any difficulties.

Thomson Pharma/Thomson Pharma Partnering subscribers can also view the histories of many of the drugs detailed, major competitor products, chemical structures and patents, by accessing directly Thomson Pharma (www.thomsonpharma.com) or Thomson Pharma Partnering (partnering.thomson-pharma.com/) in the usual way.

About Thomson Reuters

Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.
science.thomsonreuters.com

^ TOP of PAGE